
Dr. Mariam AlEissa
Project lead, WarfaRisk
Dr. Mariam AlEissa is one of the three project leads of WarfaRisk, an open research project on warfarin dose prediction.
Also written: Mariam M. AlEissa.
Publication
Dr. Mariam AlEissa is an author (corresponding author) of WarfaRisk: A Reproducible, Fairness-Aware Machine Learning Pipeline for Warfarin Dose Prediction (Prototype), AI, 2026, 7(10), 431. DOI: 10.3390/ai7100431.
Affiliations
- College of Medicine, Alfaisal University
- Public Health Laboratory, Public Health Authority
- King Khaled Eye Specialist Hospital (KKESH) Research Center
- King Abdullah Petroleum Studies and Research Center (KAPSARC)
About WarfaRisk
WarfaRisk is an open research project that predicts a weekly warfarin dose with a 90% range around it, then checks how well that range held up for each ancestry group. It is a research prototype, not tested in patients and not for clinical use.
The project is described in two peer-reviewed papers from 2026. The code and trained models are open.
Links
- Dr. Mariam AlEissa on LinkedIn
- Email: maaleissa@alfaisal.edu
- WarfaRisk project page
- WarfaRisk code on GitHub
The rest of the team
- Dr. Areej Al-Wabil
- Dr. Abdullah N. Alkattan
- Siraj Aldeen Marghalani
- Omar Bawazir
- Hassan Barmandah
- Muath Shaat
Research prototype. Not tested in patients and not for clinical use. The dose and range shown by WarfaRisk must not be used to make dosing decisions.